Investment Opportunity In Georgia

Madison - Republican Sen. Ted Kanavas of Brookfield today said the governor's plan to double the fee charged when property is sold would most hurt homeowners, already struggling with a downturn in home prices.

"While no time is a good time to raise taxes, Gov. Jim Doyle and his Democratic colleagues have chosen about the worst possible time to raise taxes on the housing market," Kanavas said in a statement. "The housing market is cooling nationwide."

Under Doyle's proposal, the real estate transfer fee would go from $3 per $1,000 of value to $6 -- an increase that would raise the cost of selling a median-valued Wisconsin home by about $492, said Kanavas. He called the change a "home tax."

The median-valued Wisconsin home was assessed for property tax purposes at $164,118 last year, according to the Legislative Fiscal Bureau.

Patient Safety Drives South Georgia Medical’s Selection of ...

Thanks to the Valdosta-based hospital's sweeping safety-driving technology initiative, nurses at the hospital will gain proven, bar-code technology to verify the five "rights" of medication administration – right medication, right patient, right dose at the right time via the right route. The goal behind the bar-coding is to reduce medication errors, which are the most common of medical errors and harm at least 1.5 million people every year nationwide, according to the federal Institute of Medicine of the National Academies.

With less than a quarter of U.S. hospitals currently using bar-code scanning technology, SGMC will join the ranks of an elite group of healthcare organizations that are using this proven and common technology, found in most retail stores, to improve patient safety and care.

Inhibitex Signs Definitive Agreement to Acquire FermaVir ...

ATLANTA--(BUSINESS WIRE)--Apr 10, 2007 - Inhibitex, Inc. (NASDAQ: INHX) announced today that it has entered into a definitive merger agreement with FermaVir Pharmaceuticals, Inc. (OTCBB: FMVR). FermaVir's development-stage antiviral pipeline includes FV-100, a highly potent nucleoside analogue for the treatment of herpes zoster infections ("shingles") that is expected to enter Phase I clinical trials in the third quarter of 2007, and a series of preclinical compounds for the treatment of human cytomegalovirus (CMV) disease.

Under the terms of the agreement, each of the 20.8 million outstanding shares of FermaVir common stock will be exchanged for 0.55 shares of Inhibitex common stock. Immediately following the transaction, Inhibitex shareholders are expected to own approximately 73 percent of the combined company.

Nationwide Financial Hosts Investment Community Conference

COLUMBUS, Ohio-(Business Wire)-March 26, 2007 - Nationwide Financial Services, Inc. (NYSE:NFS), a leading provider of long-term savings and retirement products, is hosting an investment community conference at the Jumeirah Essex House in New York City Tuesday, March 27, from 8 a.m. to 2 p.m. Eastern time. Members of senior management will be discussing the company's business strategy, outlook and financial targets.